Evotec SE

XTRA:EVT Stock Report

Market Cap: €1.7b

Evotec Management

Management criteria checks 3/4

Evotec's CEO is Mario Polywka, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.007% of the company’s shares, worth €116.21K. The average tenure of the management team and the board of directors is 2.3 years and 4.9 years respectively.

Key information

Mario Polywka

Chief executive officer

€60.0k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.007%
Management average tenure2.3yrs
Board average tenure4.9yrs

Recent management updates

Evotec SE's (ETR:EVT) CEO Looks Due For A Compensation Raise

Jun 07
Evotec SE's (ETR:EVT) CEO Looks Due For A Compensation Raise

Recent updates

Investors Aren't Entirely Convinced By Evotec SE's (ETR:EVT) Revenues

Apr 10
Investors Aren't Entirely Convinced By Evotec SE's (ETR:EVT) Revenues

These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well

Mar 05
These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well

A Piece Of The Puzzle Missing From Evotec SE's (ETR:EVT) Share Price

Jan 09
A Piece Of The Puzzle Missing From Evotec SE's (ETR:EVT) Share Price

We Think Evotec (ETR:EVT) Can Stay On Top Of Its Debt

Oct 05
We Think Evotec (ETR:EVT) Can Stay On Top Of Its Debt

Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet

Jun 28
Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Evotec SE's (ETR:EVT) 37% Undervaluation?

May 14
Is There An Opportunity With Evotec SE's (ETR:EVT) 37% Undervaluation?

Does Evotec (ETR:EVT) Have A Healthy Balance Sheet?

Feb 25
Does Evotec (ETR:EVT) Have A Healthy Balance Sheet?

Evotec (ETR:EVT) Seems To Use Debt Quite Sensibly

Jul 29
Evotec (ETR:EVT) Seems To Use Debt Quite Sensibly

Is Now The Time To Look At Buying Evotec SE (ETR:EVT)?

May 16
Is Now The Time To Look At Buying Evotec SE (ETR:EVT)?

Is Evotec (ETR:EVT) A Risky Investment?

Apr 28
Is Evotec (ETR:EVT) A Risky Investment?

Do Evotec's (ETR:EVT) Earnings Warrant Your Attention?

Mar 15
Do Evotec's (ETR:EVT) Earnings Warrant Your Attention?

At €36.91, Is It Time To Put Evotec SE (ETR:EVT) On Your Watch List?

Jan 10
At €36.91, Is It Time To Put Evotec SE (ETR:EVT) On Your Watch List?

Evotec (ETR:EVT) Takes On Some Risk With Its Use Of Debt

Nov 14
Evotec (ETR:EVT) Takes On Some Risk With Its Use Of Debt

Is It Time To Consider Buying Evotec SE (ETR:EVT)?

Oct 10
Is It Time To Consider Buying Evotec SE (ETR:EVT)?

Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet

Aug 16
Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet

Is It Time To Consider Buying Evotec SE (ETR:EVT)?

Jul 03
Is It Time To Consider Buying Evotec SE (ETR:EVT)?

Evotec SE's (ETR:EVT) CEO Looks Due For A Compensation Raise

Jun 07
Evotec SE's (ETR:EVT) CEO Looks Due For A Compensation Raise

These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well

Apr 30
These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well

Evotec SE's (ETR:EVT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 21
Evotec SE's (ETR:EVT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

CEO Compensation Analysis

How has Mario Polywka's remuneration changed compared to Evotec's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-€84m

Sep 30 2023n/an/a

-€95m

Jun 30 2023n/an/a

-€103m

Mar 31 2023n/an/a

-€117m

Dec 31 2022€60kn/a

-€176m

Sep 30 2022n/an/a

-€180m

Jun 30 2022n/an/a

€2m

Mar 31 2022n/an/a

€90m

Dec 31 2021€56kn/a

€216m

Sep 30 2021n/an/a

€247m

Jun 30 2021n/an/a

€112m

Mar 31 2021n/an/a

€42m

Dec 31 2020€50kn/a

€6m

Sep 30 2020n/an/a

€14m

Jun 30 2020n/an/a

€35m

Mar 31 2020n/an/a

€42m

Dec 31 2019€27kn/a

€38m

Sep 30 2019n/an/a

€61m

Jun 30 2019n/an/a

€77m

Mar 31 2019n/an/a

€94m

Dec 31 2018€846k€316k

€84m

Sep 30 2018n/an/a

€63m

Jun 30 2018n/an/a

€31m

Mar 31 2018n/an/a

€20m

Dec 31 2017€816k€320k

€23m

Compensation vs Market: Mario's total compensation ($USD64.01K) is below average for companies of similar size in the German market ($USD1.61M).

Compensation vs Earnings: Mario's compensation has increased whilst the company is unprofitable.

CEO

Mario Polywka (60 yo)

less than a year

Tenure

€60,000

Compensation

Dr. Mario Polywka, Ph D., D.Phil., serves as Director at Blacksmith Medicines, Inc. He was Independent Member of the Supervisory Board at Evotec SE since June 19, 2019 and also serves as its Chairman of th...

Leadership Team

NamePositionTenureCompensationOwnership
Mario Polywka
CEO & Chairman of the Management Board & Member of the Supervisory Boardless than a year€60.00k0.0067%
€ 116.2k
Cord Dohrmann
Chief Scientific Officer & Member of Management Board13.7yrs€1.40m0.11%
€ 1.9m
Craig Johnstone
COO & Member of Management Board5.3yrs€2.11m0.011%
€ 196.3k
Matthias Evers
Chief Business Officer & Member of Management Board2.3yrs€1.54mno data
Laetitia Rouxel
CFO & Member of Management Board1.1yrsno data0.029%
€ 503.2k
Anja Bosler
Principal Accounting Officer and Senior Vice President of Group Accountingno datano datano data
Volker Braun
Executive VP and Head of Global Investor Relations & ESGno datano datano data
Christian Dargel
EVP Global Head of Legal & Complianceno datano datano data
Gabriele Hansen
Senior VP & Head of Global Corporate Communications & Marketingno datano datano data
Ian Hunneyball
Senior Vice President of Programme Management & Clinical Operationsno data€116.00kno data
David Hallet
Executive Vice Presidentno datano datano data
Uwe Andag
EVP Head of Metabolic Diseasesno datano datano data

2.3yrs

Average Tenure

56yo

Average Age

Experienced Management: EVT's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mario Polywka
CEO & Chairman of the Management Board & Member of the Supervisory Board4.9yrs€60.00k0.0067%
€ 116.2k
Roland Sackers
Independent Vice Chairperson of the Supervisory Board4.9yrs€95.00kno data
Iris Low-Friedrich
Independent Chairperson of the Supervisory Board9.9yrs€150.00kno data
Elaine Sullivan
Independent Member of Supervisory Board8.9yrs€65.30kno data
Camilla Languille
Member of the Supervisory Board1.9yrs€31.60kno data
Constanze Ulmer-Eilfort
Independent Member of Supervisory Board2.9yrs€73.20kno data

4.9yrs

Average Tenure

60yo

Average Age

Experienced Board: EVT's board of directors are considered experienced (4.9 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.